fb
X
X
Tired?
Unfocused?
Off your game?
Read our free, updated as of Mar 3, 2022, Dr K report on how to optimize your mind and body so you can boost your focus when trading the markets.
YES, SEND ME THE REPORT !
Meet Dr K !
Chris Kacher
  • Nuclear physicist
  • Stock & crypto market wizard
  • Blockchain builder
  • Bestselling author
  • Top 40 charted musician
  • Biohacker
  • Former computer hacker
YES, SEND ME THE FILE !
YES, SEND ME BOTH !
Your email will always remain private.

MLR - PMP 9/27/13

The major market averages managed to close positive yesterday, but did so on lighter volume. The NASDAQ Composite remains with an eyelash of its prior September high, but the S&P 500 is bouncing feebly after closing lower for five days in a row. Churning and intra-day volatility have been the earmark of the market's action over the past week. Accumulation days where the market rises on higher volume have been scarce, but the Fed's green light on continued levels of quantitative easing, easing tensions in Syria, and Janet Yellen as QE-friendly frontrunner to replace Bernanke have all served to push the market higher though in perhaps volume-reluctant fashion.

That could be a sign that the unemployment rate remains a big issue and thus not all is well on the economic road to recovery. Nevertheless, QE continues to step the market higher this year.

Pharmacyclics (PCYC) had a buyable gap up on an analyst upgrade. It traded enough volume for a pocket pivot as well. It has been a biotech leader though can be a choppy trader so position size with care. We have reported on PCYC before including its most recent pocket pivot on September 3.

With a potential U.S. government shut-down looming ahead on Monday, investors should expect some volatility heading into the weekend.

This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.
FOR OUR FREE MARKET LAB REPORT :
Copyright ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing.
All Rights Reserved.
privacy policy